Publications
Education
Events

Articles and Books

2020 Mennini FS, Rossi D, Bini C, Rotundo MA, Cerveri G, Diadema E, Marcellusi A. Analisi di costo-utilità probabilistica di lurasidone rispetto allo standard di cura in pazienti con schizofrenia in Italia. GIHTAD (2020) 13:5.

2020 Gitto L, Massini G, Mennini FS, Mento S, Buscema PM. AFFECTIVE SYMPTOMS AND POSTURAL ABNORMALITIES AS PREDICTORS OF HEADACHE: AN APPLICATION OF ARTIFICIAL NEURAL NETWORKS, Neural Network World 1/2020, 1–26. DOI: 10.14311/NNW.2020.30.001. 2020. (IF: 1.08).

2020 Marcellusi A, Bini C, Peris K, Ascierto PA, Mennini FS. Cost of illness del carcinoma cutaneo a cellule squamose (CSCC). Global & Regional Health Technology Assessment, 2020. (IF:0.25).

2020 P Berto, A Aiello, G Procopio, R Iacovelli, FS Mennini. Costo-Efficacia di cabozantinib nel trattamento di prima linea del tumore a cellule renali avanzato (aRCC) in Italia. GIHTAD (2020)

2020 Perrone V, Sangiorgi D, Andretta M, Ducci G, Forti B, Francesa Morel PC, Gambera M, Maina G, Mencacci C, Mennini FS, Zanalda E, Degli Esposti L. Assessment of Patients Affected by Treatment-Resistant Depression: Findings from a Real-World Study in Italy. J Psychiatry Psychiatric Disord 2020; 4 (3): 104-117. 2020. (IF: 2.6).

2020 Kondili LA, Mennini FS, Andreoni M, Babudieri S, Gardini I, Rossi A, Russo FP, Nava FA, Vella S. “Verso una politica sanitaria di screening e linkage to care per l’eliminazione dell’infezione da epatite C in Italia”. Le Infezioni in Medicina, Speciale 2, 5-28, 2020.

2020 Marcellusi A, Bini C., Rotundo MA, Cultrera R, Mennini FS. Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia. (Cost-utility of dalbavancin in patients with non-severe ABSSSI in Italy). Global & Regional Health Technology Assessment, 2020. (IF:0.25).

2020 Kondili LA, Gamkrelidze I, Blach S, Marcellusi A, Galli M, Petta S, Puoti M, Vella S, Razavi H, Craxi A, Mennini FS, on behalf of the PITER collaborating group. Optimization of hepatitis C virus screening strategies by birth cohort in Italy. ORIGINAL ARTICLE. Liver International. 2020; 00:1–11. John Wiley & Sons Ltd (IF: 5.542)

2020 A Marcellusi, C Bini, M Andreoni, L Sarmati, J Espin, J P Horcajada, T Czypionka, D Andretta, P Sciattella, G Favato, FS Mennini. Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries. Clinical Drug Investigation. https://doi.org/10.1007/s40261-020-00891-w. 2020. (IF: 2.158)

2020 Marcellusi A, Rotundo M, Nardone C, Sciattella P, Gazzillo S, Rossini M, Barbagallo M, Antenori A, Valle D, Mennini FS. Osteoporosis: Economic Burden of Disease in Italy. Clinical Drug Investigation https://doi.org/10.1007/s40261-020-00904-8. 2020. (IF: 2.158)

2020 Mennini FS, Luciani A, Gitto L, Waste and Corruption in Health Care. Chapter 14 in : “Corruption in the Global Era. Causes, Sources and Forms of Manifestation”, By Lorenzo Pasculli, Nicholas Ryder. ISBN 9780367660550. Published September 30, 2020 by Routledge.

2019 Vardé A, Mennini FS. Il personale del Servizio Sanitario Nazionale - evoluzione e prospettive nella programmazione sanitaria. Mecosan. Issue: 110, Pg. 9-43,DOI: 10.3280/MESA2019-110002, 2019. (IF:0.14)

2019 Negro A, Sciattella P, Rossi D, Guglielmetti M, Martelletti P, Mennini FS. Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre. The Journal of Headache and Pain 2019 20:120. (IF:4.797).

2019 Gardini I, Bartoli M, Conforti M, Mennini FS, Marcellusi A, Estimation of the number of HCV-positive patients in Italy. PLoS ONE 14(10): e0223668. (2019).

2019 C Bini, A Marcellusi, FS Mennini, M Romagnoli, V Sartori, B Pingue. Burden economico della neuropatia ottica ereditaria di Leber (LHON) in Italia: stima dei costi indiretti e diretti a carico del paziente. HTA Focus Volume 6, n. 1 (2019); 27-34. DOI 10.23753/htafocus. 2019.01.004

2019 A Marcellusi, C Bini, P Sciattella, D Rossi, S Taddei, M Uguccioni, F Fanelli, L Gazzi, FS Mennini. Ipercolesterolemia e rischio cardiovascolare in Italia: modello di cost of illness. HTA Focus Volume 6, n. 1 (2019); 7-19. DOI 10.23753/htafocus 2019.01.002

2019 Mennini FS, Fabiano G, Favato G, Sciattella P, Bonanni P, Pinto C, Marcellusi A, Economic burden of HPV9-related diseases: a real-world cost analysis from Italy, (Original Article), The European Journal of Health Economics, 2019. (IF:2.367).

2019 Sciattella P, Pellacani G, Pigatto P, Patrizi P, Peris K, Calzavara-Pinton P, Girolimoni G, Lanati E, D'Ausilio A, Mennini FS. The burden of atopic dermatitis in adults in Italy. G Ital Dermatol Venereol. 2020 Feb;155(1):19-23. doi: 10.23736/S0392-0488.19.06430-7. Epub 2019 Sep 12. (IF: 1.056).

2019 Mennini FS, A Marcellusi, C Bini, M A Rotundo, A Giunta, A Gasbarrini, G Valesini, PL Canonico, E Novellino, V Orlando, A Mecozzi, T Gamucci, L Pagano, E Di Brino, M Ruggeri, A Cicchetti. The economic impact of biosimilars in Italy: a scenario analysis. Global & Regional Health Technology Assessment, Volume 2019: 1–8, 2019. DOI: 10.1177/228424031985802. (IF:0.25).

2019 A Paderno, A Garolla, S Pecorelli, A Lombardi, C Pinto, G Icardi, F Bonetti, FS Mennini, M Conversano, A Isidori, L Mariani, G Rezza, A Peracino. HPV Vaccination Concepts in the Reality of Today. J Vaccines Vaccin 2019, 10:1.DOI: 10.4172/2157-7560.1000403.

2019 Mennini FS, Marcellusi A, Fabiano G, Rimassa L, Santoro A & Personeni N. Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer. Future Oncology, doi.org/10.2217/fon-2018-0904, 2019. (IF:2.660).

2019 Mennini FS, Trabucco Aurilio M, Russo S, Migliorini R, Piccioni M, Ricci F. Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness. Pharmacoeconomics OpenAcess. Pharmacoeconomics 4:120. 2019 (doi: 10.4172/2472-1042.1000120. (IF:3.705)

2019 Marcellusi A, Viti R, Sarmati L, Streinu-Cercel A5, Pana A, Espin J, Horcajada Gallego P, Favato G, Andretta D., Soro M, Andreoni M, Mennini FS. Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries, Expert Review of Pharmacoeconomics & Outcomes Research - Taylor & Francis, 2019. (IF:2.032).

2019 Marcellusi A, Kondili L, Viti R, Vella S, Mennini FS, ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE: a real-world-based analysis from PITER data. PharmacoEconomics (2019). https://doi.org/10.1007/s40273-018-0733-3. 2019. (IF:3.563).

2019 LA Kondili, A Marcellusi, I Gamkrelidze, S Blach, S Robbins, A Craxì, M Puoti, S Vella, H Razavi, FS Mennini. Screening strategies for Hepatitis C Virus elimination in Italy. Digestive and Liver Disease. 51, e68. 2019. (IF:3.57)

2019 FS Mennini, A Marcellusi, G Fabiano, F Platini, P Bossi. Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer. Head & neck. 2019. (IF:2.53)

2018 Mennini FS, Sciattella P, Marcellusi A, Toraldo B, Koch M. Burden of diverticular disease: an observational analysis based on Italian real-world data. Recenti Prog Med. 2018 Jan;109(1):15-24.

2018 Marcellusi A, Fabiano G, Viti R, Francesa Morel PC, Nicolò G, Siracusano A, Mennini FS. Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis. BMJ Open. 2018 Feb 8;8(2):e018359.

2018 Di Nardo F, Boccalini S, Calabrò GE, Marcellusi A, Ruggeri M, Bonanni P, Vitali R, Capannini E, Mennini FS, Cicchetti A, Panatto D, Gasparini R, Ricciardi W, De Waure C. The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports. Ig Sanita Pubbl. 2017 Sep-Oct;73(5):453-471

2018 Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M. Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy. Clinicoecon Outcomes Res. 2018 Jan 10;10:45-51.

2017 Mennini FS, Fabiano G, Marcellusi A, Sciattella P, Saia M, Cocchio S, Baldo V. Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study. Clin Drug Investig. 2017 Oct 28

2017 Marcellusi A. Impact of HPV vaccination: health gains in the Italian female population. Popul Health Metr. 2017 Sep 29;15(1):36. (IF 2016: 2.910)

2017 Ferrandina G, Amadio G, Marcellusi A, Azzolini E, Puggina A, Pastorino R, Ricciardi W, Scambia G. Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment. Clin Drug Investig. 2017 Nov;37(11):1093-1102. (IF 2016: 1.853)

2017 Mennini FS, Sciattella P, Marcellusi A, Toraldo B, Koch M. Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region. Dig Liver Dis. 2017 Sep;49(9):1003-1008. (IF 2016: 3.061)

2017 Mennini FS, Sciattella P, Marcellusi A, Marcobelli A, Russo A, Caputi AP. Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):503-510

2016 Gardini I, Bartoli M, Conforti M, Mennini FS, Marcellusi A, Lanati E. HCV - Estimation of the number of diagnosed patients eligible to the new anti-HCV therapies in Italy. Eur Rev Med Pharmacol Sci. 2016 Dec;20(1Suppl):7-10.

2016 Mennini FS, Marcellusi A, Gitto L, Iannone F. Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients. Clin Drug Investig. 2017 Jan 10. doi:10.1007/s40261-016-0491-y. [Epub ahead of print] (IF 2016 = 1.806)

2016 Capone A, Cicchetti A, Mennini FS, Marcellusi A, Baio G, Favato G. Health Data Entanglement and artificial intelligence-based analysis: a brand new methodology to improve the effectiveness of healthcare services. Clin Ter. 2016 Sep-Oct;167(5):e102-e111. doi: 10.7417/CT.2016.1952.

2016 Marcellusi A, Viti R, Sciattella P, Aimaretti G, De Cosmo S, Provenzano V, Tonolo G, Mennini FS. Economic aspects in the management of diabetes in Italy. BMJ Open Diabetes Res Care. 2016 Oct 10;4(1):e000197.

2016 Marcellusi A, Viti R, Damele F, Cammà C, Taliani G, Mennini FS. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective? Clin Drug Investig. 2016 Aug;36(8):661-72. doi: 10.1007/s40261-016-0414-y. (IF 2016 = 1.806)

2016 Brugnoli R, Rapinesi C, Kotzalidis GD, Marcellusi A, Mennini FS, De Filippis S, Carrus D, Ballerini A, Francomano A, Ducci G, Del Casale A, Girardi P Model of Management (Mo.Ma) for the patient with schizophrenia: crisis control, maintenance, relapse prevention, and recovery with long-acting injectable antipsychotics (LAIs). Riv Psichiatr. 2016
Mar-Apr;51(2):47-59. doi: 10.1708/2246.24194. Italian.

2016 Marcellusi A, Viti R, Russo S, Andreoni M, Antinori A, Mennini FS. Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective. Clin Drug Investig. 2016 Mar 3. [Epub ahead of print] (IF 2016 = 1.806)

2016 2016 Buscema, PM, Maurelli G, Mennini FS, Gitto L, Russo S, Ruggeri M, Coretti S, Cicchetti A. Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory. Qual Quant (2016). doi:10.1007/s11135-016-0329-y (IF 2016 = 0.867)

2016 Buscema, PM, Gitto L, Russo S, Marcellusi A, Fiori F, Maurelli G, Massini G, Mennini FS. The perception of corruption in health: AutoCM methods for an international comparison. Qual Quant (2016). doi:10.1007/s11135-016-0315-4 (IF 2016 = 0.867)

2016 Gasparini R, Mennini FS, Panatto D, Bonanni P, Bechini A, Ricciardi W, DE Waure C, Marcellusi A, Cicchetti A, Ruggeri M, Boccalini S. How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project. J Prev Med Hyg. 2015;56(4):E150-4.

2015 Haeussler K, Marcellusi A, Mennini FS, Favato G, Picardo M, Garganese G, Bononi M, Costa S, Scambia G, Zweifel P, Capone A, Baio G. Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study. Value Health. 2015 Dec;18(8):956-68. (IF 2013 = 3.279)

2015 Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE. Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country. Eur J Health Econ. 2015 Jan;16(1):65-72. (IF 2013 = 2.095)

2015 Marcellusi A, Viti R, Capone A, Mennini FS. The economic burden of HCV-induced diseases in Italy. A probabilistic cost of illness model Eur Rev Med Pharmacol Sci 19 (9), 1610-1620. (IF 2015 = 1.089)

2015 Pistilli B, Marcellusi A, Latini L, Accardi R, Ferretti B, Benedetti G. Cardiotoxicity related to long-term trastuzumab therapy in metastatic breast cancer: the potential role of treatment duration and cardiac risk factors. Breast J. 2015 May;21(3):318-21. (IF 2015 = 2.581)

2014 Mennini FS, Marcellusi A, von der Schulenburg JM, Gray A, Levy P, Sciattella P, Soro M, Staffiero G, Zeidler J, Maggioni A, Schmieder RE. Cost of poor adherence to anti-hypertensive therapy in five European countries. Eur J Health Econ. 2014 Jan 5. [Epub ahead of print] (IF 2013 = 2.095)

2013 FS Mennini, S Russo, A Marcellusi, F. Palazzo, P Quintaliani. Cost-effectiveness analysis for the treatment of chronic kidney disease with low-protein diet. Functional Foods in Health and Disease 2013; 3(7):259-273

2013 F.S. Mennini, A. Marcellusi, G. Baio, K. Haeussler, G. Favato, A. Capone. Loss of health utilities due to hpv-induced diseases in men and women: A multicenter italian study. Value in Health May 2013(Vol. 16, Issue 3,Page A38) (IF 2013 = 2.191)

2013 Favato G, Baio G, Capone A, Marcellusi A and Mennini FS. A Novel Method to Value Real Options in Health Care: The Case of a Multicohort Human Papillomavirus Vaccination Strategy. Clin Ther. 2013 Jun 24. doi:pii: S0149-2918 (IN PRESS). (IF 2013 = 2.230)

2013 Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini FS. Transparency or Proper Study Valuation Proce-dures Missed? Medical Care. Vol XX, Number XX, 2013. (IF 2011 = 3.411)

2012 G Baio, A Capone, A Marcellusi, FS Mennini, G Favato. Economic Burden of Human Papillomavirus-Related Diseases in Italy.PLoSOne. 2012;7(11): (IF 2011 = 4.092)

2012 F.S. Mennini, A. Marcellusi, E. Arduini, G. Mauro, A. Mecozzi, A. Tuzi, E. Cortesi. Terapia oralevsterapiainfusionale nel trattamento del cancro del colon retto localmente avanzato o avanzato Analisi di minimizzazione dei costi presso una struttura ospedaliera della Regione Lazio. PharmacoEconomics–ItalianResearchArticles 2012; 14 (2): 121-129 (Italian Journal)

2012 M. Ruggeri, S. Coretti, R. Di Bidino, A. Marcellusi, F. Mennini, A. Cicchetti. Valutazione economica dei programmi di screening contro il cancro del colon retto: evidenze indirette di lungo periodo e sostenibilita` finanziaria in un’ottica di programmazione regionale. PharmacoEconomics–Italian Research Articles 2012; 14 (2): 101-120. (Italian Journal)

2012 FS Mennini, S Russo, A Marcellusi. “Budget impact analysis resulting from the use of dabigatranetexilate in preventing stroke in patients with non-valvular atrial fibrillation in Italy”.Farmeconomia. Health economics and therapeutic pathways Vol 13, No 3 (2012) 121-131. (Italian Journal)

2012 Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini FS. Novel Health Economic Evaluation Of A Vaccination Strategy To Prevent Hpv-Related Diseases: The Best Study. Med Care. 2012 Dec;50(12):1076-1085. (IF 2011 = 3.411)

2012 FS Mennini, G Baio, G Montagano, G Cauzillo, F Locuratolo, G Becce, L Gitto, A Marcellusi, P Zweifel, A Capone, G Favato. Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study. BMJ Open. 2012 Mar 15;2(2):e000736

2012 A Lugaresi, C Florio, V Brescia-Morra, S Cottone, P Bellantonio, M Clerico, D Centonze, A Uccelli, M di Ioia, G De Luca, A Marcellusi, A Paolillo and the BRIDGE Studygroup. Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study. BMC Neurology 2012, 12:7 (IF 2011 = 2.80)

2012 Arezzo di Trifiletti A, Misino P, Giannantoni P, Giannantoni B, Cascino A, Fazi L, Rossi Fanelli F, Laviano A.“Comparison of the performance of four different tools in diagnosing disease-associated anorexia and their relationship with nutritional, functional and clinical outcome measures in hospitalized patients”.Journal of Clinical Nutrition, 2012, doi: 10.1016/j.clnu.2012.11.011 [Epub ahead of print]

2012 A Bello, P Giannantoni, P Pettenati, S Stefanini, MC Caselli. Assessing lexicon: validation and developmental data of the Picture Naming Game (PiNG), a new picture naming task for toddlers.International Journal of Language and Communication Disorders, 2012, 47(5): 589-602.

2012 Governance of preventive health intervention and on time verification of its efficiency in a Region of Southern Italy. The GIOVE study (con F.S. Mennini, G. Baio, G. Montagano, G. Cauzillo, F. Locuratolo, A. Marcellusi, M. Drummond, P. Zweifel, G. Favato), British Medical Journal Open, 2012.

2012 Relations between mood and sleep in adolescence: an econometric analysis (con S. Settineri, C. Mento, G. Polimeni et al.), Journal of Mental Health Economics and Policy, 15 (1), 2012.

2011 Ferrandina G, Mantegna G, Petrillo M, Fuoco G, Venditti L, Terzano S, Moruzzi C, Lorusso D, Marcellusi A, Scambia G. Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study. GynecolOncol. 2011 Oct 27. [Epub ahead of print] (IF 2010 = 3.760)

2011 Esposito S, Mennini F, Montorsi F, Sganga G, Leone S (2011). Management and prevention of catheter-associated urinary tract infections: current opinions and clinical practice. Le Infezioni In Medicina, vol. 19, p. 74-90, ISSN: 1124-9390

2011 FS. Mennini, D. Panatto, A. Marcellusi, P. Cristoforoni, R. De Vincenzo, E. Di Capua, G. Ferrandina, M. Petrillo, T. Sasso, C. Ricci, N. Trivellizzi, A. Capone, G. Scambia, R. Gasparini. The time trade-off procedure to measure health utilities loss with HPV-induced diseases: an Italian multicenter pilot study. ClinTher. 2011 Aug;33(8):1084-1095.e4. Epub 2011 Jul 23. (IF 2010 = 2.551)

2011 F. Patti, M. P. Amato, M. Trojano, C. Solaro,A. Pappalardo, V. Zipoli, E. Portaccio, D. Paolicelli, A. Paolillo, F. S. Mennini, A. Marcellusi, C. Ricci, M. A. Battaglia. Multiple sclerosis in Italy: cost-of-illness study. Neurol Sci. 2011 Oct;32(5):787-94. Epub 2011 Mar 16. (IF 2010 = 1.22)

2011 Mennini F, Capone A, Favato G (2011). The use of an "old-fashioned method" to assess the clinical and economic impact of a HPV vaccination program.Gynecologic Oncology, vol. 123, p. 175-176, ISSN: 0090-8258, doi: 10.1016/j.ygyno.2011.04.042

2011 L. Gitto, D. Santoro, A. Ferraro, V. Savica, G. Bellinghieri,Vitamin D status and mortality risk in patients with chronic kidney disease, Renal Failure, 33(2): 184–191, 2011.

2010 S. Costa, S. Venturoli, F.S. Mennini, A. Marcellusi, M. Pesaresi, E. Leo, A. Falasca, E. Marra, M. Cricca, D. Santini, M. Zerbini, G. Pelusi. “Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study”. Current Medical Research and Opinion Vol. 27, No. 3, 2011, 569–578 (IF 2010 = 2.609).

2010 Mennini F, Cicchetti A, Ruggeri M e Gitto L, (2010). Extending influenza vaccination to individuals aged 50-64. A budget impact analysis.International Journal Of Technology Assessment In Health Care, vol. 26, ISSN: 0266-4623, doi: 10.1017/S0266462310000280

2010 G. Ferrandina, A. Marcellusi, FS. Mennini, M. Petrillo, G. Sticca, G. Scambia Title: “Hospital costs incurred by the italian national health service for invasive cervical cancer” Gynecologic Oncology. Volume 119, Issue 2, November 2010, Pages 243-249 (IF 2010 = 3.760).

2010 P. Russo, Mennini F, P. D. Siviero, G. Rasi (2010). Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. ANNALS OF ONCOLOGY, vol. 21, p. 2081-2087, ISSN: 0923-7534, doi: 10.1093/annonc/mdq097

2010 M. Dall'Oglio, B. Rossiello, M. F. Coletti, M. C. Caselli, L. Ravà, V. di Ciommo, M. Orzalesi, P. Giannantoni, P. PasqualettiDevelopmentalevaluationatage 4: Validity of an Italianparentalquestionnaire.Journal of Paediatrics and Child Health, 2010 July, 46(7-8):419-26

2010 L. Gitto,A. DoniaSofio, L’attività di trapianto in Italia: un’analisi regionale dei flussi di domanda e offerta, Politiche Sanitarie, n. 1, 2010.

2009 Mennini F, S. Costa, G. Favato, M. Picardo (2009). Anti-HPV Vaccination in Italy: A Review of Recent Economic Data for Italy. Vaccine, vol. 27, p. 54-61, ISSN: 0264-410X, doi: 10.1016/j.vaccine.2009.02.052

2009 Mennini F, P Giorgi Rossi, F Palazzo, N Largeron(2009). Health and economic impact associated with a quadrivalent HPV vaccine in Italy. Gynecologic Oncology, vol. 112, p. 370-376, ISSN: 0090-8258, doi: 10.1016/j.ygyno.2008.09.031

2009 Mennini F (2009). Rapid responses to: “Letter to the Editor”.VACCINE, vol. 27, ISSN: 0264-410X, doi: 10.1016/j.vaccine.2009.09.049

2009 A. Vitetta, S. Settineri, L. Gitto, Construction of a telephone interview to assess the relationship between mood and sleep in adolescence, Neurological Sciences, 2009.

2009 S. Ambrogio, V. Mapelli e G. Sobbrio, L. Gitto, Analisi dei costi dell’assistenza domiciliare integrata: l’esperienza della Regione Calabria, MECOSAN, 72, 2009.

2008 Mennini F, Cicchetti A, Gitto L, Ruggeri M (2008). Analisi economica per l’estensione della vaccinazione contro l’influenza : risparmi sociali e analisi di Budget Impact. PHARMACOECONOMICS, ITALIAN RESEARCH ARTICLES, vol. 10, p. 137-150, ISSN: 1590-9158, doi: 10.2165/00136178-200810030-00002

2008 Mennini F, Gitto L, Martelletti P (2008). Improving Care Through Health Economics Analyses: Cost of Illness and Headache. The Journal Of Headache And Pain, vol. 9, p. 199-206, ISSN: 1129-2369, doi: 10.1007/s10194-008-0051-9

2008 Favato, MENNINI F,Monorchio, Mortilla(2008). 3. Comparison between product characteristics and decision analysis supporting decision-makers in public health-related choices: a study model applied to anti-HPV vaccines. SSRN.

2008 L. Gitto, D. Santoro, B. Di Iorio, V. Savica, M. Li Vecchi, G. Bellinghieri, N.G. De Santo,Survival in octogenarians dialysis patients. Analysis in two Southern Italian Regions, Journal of Nephrology, 2008, 21, suppl. 13.

2007 M. Farsi e L. Gitto, A statistical analysis of pain relief after surgical operations, Health Policy, vol. 83, issue 2-3, 2007.

2007 L. Gitto, F. Minervini, The performance of European full service airlines after liberalisation: an econometric analysis, Rivista di PoliticaEconomica, issue january-february, 2007.

2006 L. Gitto, N. Torina, Applicazione di un modello orderedlogit per la valutazione del dolore post-operatorio, Politiche Sanitarie, 2, 2006.

2006 L. Gitto, G. Sobbrio e D. Santoro,Choice of dialysis treatment and type of medical unit in a recursive bivariate probit, Health Economics, 15, (11), 2006.

2005 MENNINI F, GIANFRATE F, SPANDONARO F (2005). Dinamiche e Determinanti del Settore Farmaceutico in Europa. L'INDUSTRIA, vol. 1, p. 103-118, ISSN: 0019-7416, doi: 10.1430/19610

2005 L. Gitto, Un problema di allocazione efficiente in sanità: la scelta tra metodiche alternative di dialisi, Politiche Sanitarie, 1, 2005.

2005 Dialysis modality selection according to the medical care provided at dialysis units. An econometric analysis, Health Services and Outcomes Research Methodology, n. 3/4, 2005.

2004 Mennini F, Palazzo F, Piasini L. e Martelletti P (2004). A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache. THE JOURNAL OF HEADACHE AND PAIN, vol. 5, p. 188-191, ISSN: 1129-2369, doi: 10.1007/s10194-004-0099-5

2004 Mennini F, Fioravanti L, Piasini L, Palazzo F, Coloprisco G, Martelletti P (2004). A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache . THE JOURNAL OF HEADACHE AND PAIN, vol. 5, p. 192-196, ISSN: 1129-2369, doi: 10.1007/s10194-004-0100-3

2004 Mennini F, Spandonaro F, Atella V (2004). Criteri per l’allocazione Regionale delle risorse per la sanità: riflessioni sul caso Italiano. POLITICHE SANITARIE, vol. 5, ISSN: 1590-069X, doi: 10.1706/29.258

2003 Mennini F, DoniaSofio A, Mazzuca F (2003). General Disease Costing Principles. THE JOURNAL OF HEADACHE AND PAIN, vol. 4, p. 55-58, ISSN: 1129-2369, doi: 10.1007/s101940300010

2003 Mennini F, Spandonaro F (2003). Strategie e Performance delle Grandi Aziende Farmaceutiche in Italia (1979-2001). L'INDUSTRIA, vol. 2, p. 333-350, ISSN: 0019-7416, doi: 10.1430/9206

2003 Mennini F, Spandonaro F (2003). Struttura e organizzazione funzionale della cardiologia. ITALIAN HEART JOURNAL, ISSN: 1129-471X

2003 Mennini F, Corrado L, LondonoD.A, Trovato G (2003). The Welfare States in a United Europe.EUROPEAN POLITICAL ECONOMY REVIEW, vol. 1, p. 40-55, ISSN: 1742-5697

2003 L. Gitto, G. Sobbrio,L’evoluzione dei sistemi di finanziamento della sanità in Italia: dall’offerta centralizzata al federalismo fiscale, Notizie di Politeia, 2, 2003.